Logo

rheumatoid arthritis

Scipher Medicine Raises $82M in Series C Financing

Scipher will use the proceeds to further commercialize PrismRA, a molecular test intended to guide treatment decisions for patients with rheumatoid arthritis.

Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence

The changes follow a strategic review and are part of the company's previously announced plans for growing its revenues and reducing costs. 

Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test

Ambry will provide RNA sequencing for Scipher's PrismRA blood test to predict response to TNF inhibitor therapies in rheumatoid arthritis patients.

Scipher Medicine to Launch PrismRA Anti-TNF Response Predictor Following Positive Data Publication
Premium

The gene expression test retrospectively identified rheumatoid arthritis patients significantly less likely to respond to TNF inhibitor therapy.

Rheumatoid Arthritis Flare-Up Clues Found in Blood Transcriptomes Tested Over Time

A pre-flare-up transcriptional profile in the blood led the team to a group of "pre-inflammation mesenchymal," or PRIME, cells in rheumatoid arthritis.

Jun 9, 2020

Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed
Premium

Apr 17, 2020

Svar Life Science, Nimble Therapeutics Form Diagnostics Alliance

Feb 19, 2020

Scipher Medicine Raises Series B Financing Total to $25M

Dec 19, 2019

Scipher Medicine Closes Series B Funding Round

Apr 9, 2019

Somalogic Collaborating With Janssen on Protein Biomarker Research

Jan 9, 2019

Scipher Medicine Builds Evidence for Tests Predicting Response to Autoimmune Disease Drugs
Premium

Sep 18, 2018

Type 1 Diabetes, Rheumatoid Arthritis Causal Variants Defined by Fine Mapping, Functional Analyses

Sep 4, 2018

Identical Twins With, Without Rheumatoid Arthritis Have Differentially Variable DNA Methylation

Jul 18, 2018

Kroger Prescription Plans to Offer Myriad Genetics' Vectra DA as Benefit Option

May 8, 2018

Myriad's Fiscal Q3 Revenues Fall 2 Percent but Beat Wall Street Expectations

May 7, 2018

HTG Molecular, Firalis Ink Deal for RA Theranostic Technology

Apr 11, 2018

Pfizer, Oxford BioDynamics, U of Glasgow Researchers Develop Approach to Gauge Response to RA Drug
Premium

Dec 7, 2017

BGI, Sanguine BioSciences Developing Patient Database for Trial Recruitment

Jan 20, 2017

Immunovia's Blood-Based Array Test for Lupus Advances in New Study
Premium

Jan 5, 2017

Metabolon, InnVentis Partner to Study Metabolomics in Inflammatory Disease

Dec 30, 2016

Myriad Disputes Research, Reasoning Underpinning Medicare Proposal to End Vectra DA Coverage
Premium

Dec 15, 2016

Johns Hopkins Team Identifies Link Between Periodontal Disease, Rheumatoid Arthritis

Nov 4, 2016

Crescendo Bioscience Studies at Upcoming ACR Meeting Explore Expanded Uses for Vectra DA
Premium

Aug 25, 2016

DREAM Challenge Models Suggest SNPs Won't Improve Rheumatoid Arthritis Treatment Response Prediction
Premium

Jul 7, 2016

HTG Molecular Diagnostics, Firalis Partner on NGS-Based RA Theranostic

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.